Warfarin and absolute risk of hemorrhagic stroke.
作者信息
Gonzalez-Perez Antonio, Gaist David, Garcia Rodriguez Luis A
出版信息
CMAJ. 2013 May 14;185(8):687. doi: 10.1503/cmaj.113-2115.
Abstract
摘要
相似文献
1
Warfarin and absolute risk of hemorrhagic stroke.华法林与出血性中风的绝对风险
CMAJ. 2013 May 14;185(8):687. doi: 10.1503/cmaj.113-2115.
2
Bleeding risk on warfarin among elderly patients with atrial fibrillation.老年房颤患者服用华法林后的出血风险
J Am Coll Cardiol. 2010 Mar 2;55(9):932; author reply 932-3. doi: 10.1016/j.jacc.2009.11.037.
3
[Warfarin should not be recommended to anyone with atrial fibrillation].华法林不应该被推荐给任何患有心房颤动的人。
Lakartidningen. 2017 May 11;114:EMSZ.
4
Comparison of Bleeding Risk Scores in Patients With Nonvalvular Atrial Fibrillation Starting Direct Oral Anticoagulants.开始使用直接口服抗凝剂的非瓣膜性心房颤动患者出血风险评分的比较
Rev Esp Cardiol (Engl Ed). 2017 Oct;70(10):878-880. doi: 10.1016/j.rec.2017.01.021. Epub 2017 Feb 24.
5
New anticoagulants offer options beyond warfarin to reduce stroke risk.
JAMA. 2012 Nov 7;308(17):1727-8. doi: 10.1001/jama.2012.14623.
6
Atrial fibrillation: Risk of bleeding with dabigatran versus warfarin particularly high in CKD.心房颤动：在慢性肾脏病患者中，达比加群与华法林相比，出血风险特别高。
Nat Rev Nephrol. 2015 Jan;11(1):3. doi: 10.1038/nrneph.2014.221. Epub 2014 Nov 25.
7
Oral anticoagulant treatment in very elderly patients with atrial fibrillation.
Compr Ther. 2001 Spring;27(1):7-10. doi: 10.1007/s12019-001-0002-8.
8
Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.新型口服抗凝剂在心房颤动中的应用：与华法林相比的大型随机对照试验的荟萃分析。
Clin Cardiol. 2013 Feb;36(2):61-7. doi: 10.1002/clc.22081. Epub 2013 Jan 21.
9
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
10
Good old warfarin for stroke prevention in atrial fibrillation.用于心房颤动中风预防的老牌药物华法林。
Lancet. 2006 Jun 10;367(9526):1877-8. doi: 10.1016/S0140-6736(06)68819-3.
引用本文的文献
1
APOE ε variants increase risk of warfarin-related intracerebral hemorrhage.载脂蛋白E（APOE）ε变体增加华法林相关脑出血的风险。
Neurology. 2014 Sep 23;83(13):1139-46. doi: 10.1212/WNL.0000000000000816. Epub 2014 Aug 22.
本文引用的文献
1
Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network.一般人群中出血性卒中的发病率：来自健康改善网络的数据验证。
Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):176-82. doi: 10.1002/pds.3391. Epub 2012 Dec 10.
2
Rates of hemorrhage during warfarin therapy for atrial fibrillation.华法林治疗心房颤动期间的出血率。
CMAJ. 2013 Feb 5;185(2):E121-7. doi: 10.1503/cmaj.121218. Epub 2012 Nov 26.
Zotero 插件